{"id":66181,"date":"2023-12-04T07:07:18","date_gmt":"2023-12-04T11:07:18","guid":{"rendered":"https:\/\/coinscreed.com\/staging\/?p=66181"},"modified":"2023-12-04T07:07:22","modified_gmt":"2023-12-04T11:07:22","slug":"astrazeneca-ai-company-absci-partner-to-find-cancer-cure","status":"publish","type":"post","link":"https:\/\/coinscreed.com\/staging\/astrazeneca-ai-company-absci-partner-to-find-cancer-cure\/","title":{"rendered":"AstraZeneca, AI Company Absci Partner to Find Cancer Cure"},"content":{"rendered":"\n<p>AstraZeneca, the pharmaceutical company that developed one of the COVID-19 vaccines, will collaborate with Absci, an <a href=\"https:\/\/coinscreed.com\/staging\/us-copyright-office-initiates-inquiry-on-artificial-intelligence.html\" target=\"_blank\" rel=\"noreferrer noopener\">artificial intelligence <\/a>(AI) biologics company based in the United States, to develop a cancer antibody.<\/p>\n\n\n\n<figure class=\"wp-block-image aligncenter size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"549\" src=\"https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-1024x549.png\" alt=\"AstraZeneca, AI Company Absci Partner to Find Cancer Cure\" class=\"wp-image-66184\" srcset=\"https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-1024x549.png 1024w, https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-300x161.png 300w, https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-768x411.png 768w, https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-18x10.png 18w, https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5-750x402.png 750w, https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5.png 1049w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><figcaption class=\"wp-element-caption\">AstraZeneca, AI Company Absci Partner to Find Cancer Cure<\/figcaption><\/figure>\n\n\n\n<p>The Financial Times reported on December 3 that AstraZeneca intends to allocate a maximum of $247 million towards research and development, milestone payments, and an upfront fee in relation to Absci. <\/p>\n\n\n\n<p>The goal of the collaboration is to develop a zero-shot <a href=\"https:\/\/coinscreed.com\/staging\/china-enforces-stricter-rules-for-training-ai-generative-models.html\" target=\"_blank\" rel=\"noreferrer noopener\">generative AI model <\/a>that will aid in developing new antibody therapeutics for cancer and enhancing existing ones. The report failed to provide a specific identification of the cancer type or types implicated.<\/p>\n\n\n\n<p>According to Absci's website, its artificial intelligence examines &#8220;billions of cells&#8221; weekly and transforms antibodies into wet &#8220;lab-validated candidates&#8221; within six weeks. Currently, seventeen active initiatives involve the organization. As stated by Puja Sapra, senior vice president of AstraZeneca:<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201cAI is enabling us to not only increase the success and speed of our biologics discovery process, but also enhance the diversity of the biologics we discover.\u201d<\/em><\/p>\n<\/blockquote>\n\n\n\n<p>According to a report by Reuters, <a href=\"https:\/\/www.absci.com\/about-us\/team\/\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">Absci CEO Sean McClain<span class=\"wpil-link-icon\" title=\"Link goes to external site.\" style=\"margin: 0 0 0 5px;\"><svg width=\"24\" height=\"24\" style=\"height:16px; width:16px; fill:#000000; stroke:#000000; display:inline-block;\" viewBox=\"0 0 24 24\" version=\"1.1\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:svg=\"http:\/\/www.w3.org\/2000\/svg\"><g id=\"wpil-svg-outbound-7-icon-path\" fill=\"none\" clip-path=\"url(#clip0_31_188)\">\r\n                            <path d=\"M9.16724 14.8891L20.1672 3.88908\" stroke-linecap=\"round\"\/>\r\n                            <path d=\"M13.4497 3.53554L20.5208 3.53554L20.5208 10.6066\" stroke-linecap=\"round\" stroke-linejoin=\"round\"\/>\r\n                            <path d=\"M17.5 13.5L17.5 16.26C17.5 17.4179 17.5 17.9968 17.2675 18.4359C17.0799 18.7902 16.7902 19.0799 16.4359 19.2675C15.9968 19.5 15.4179 19.5 14.26 19.5L7.74 19.5C6.58213 19.5 6.0032 19.5 5.56414 19.2675C5.20983 19.0799 4.92007 18.7902 4.73247 18.4359C4.5 17.9968 4.5 17.4179 4.5 16.26L4.5 9.74C4.5 8.58213 4.5 8.0032 4.73247 7.56414C4.92007 7.20983 5.20982 6.92007 5.56414 6.73247C6.0032 6.5 6.58213 6.5 7.74 6.5L11 6.5\" stroke-linecap=\"round\"\/>\r\n                        <\/g>\r\n                        <defs>\r\n                            <clipPath id=\"clip0_31_188\">\r\n                                <rect fill=\"white\" height=\"24\" width=\"24\"\/>\r\n                            <\/clipPath>\r\n                        <\/defs><\/svg><\/span><\/a> had also publicly affirmed the partnership, stating that AstraZeneca would assist in capitalizing on Absci's AI efforts.<\/p>\n\n\n\n<p>The healthcare sector is witnessing a surge in the adoption of AI due to its potential to greatly enhance the speed of groundbreaking research and the precision of data analysis. <\/p>\n\n\n\n<p>In November, the Hospital Authority of Hong Kong announced the initiation of an AI pilot program to combat superbugs and multidrug-resistant organisms.<\/p>\n\n\n\n<p>By analyzing clinical data, the AI will ascertain whether or not it is necessary to prescribe antibiotics, the excessive use of which has contributed to the proliferation of superbugs that are resistant to treatment on the island.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca, the pharmaceutical company that developed one of the COVID-19 vaccines, will collaborate with Absci, an artificial intelligence (AI) biologics company based in the United States, to develop a cancer antibody. The Financial Times reported on December 3 that AstraZeneca intends to allocate a maximum of $247 million towards research and development, milestone payments, and [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":66184,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[9],"tags":[6803,17454,17453,16781],"class_list":["post-66181","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech","tag-ai-2","tag-absci","tag-astrazeneca","tag-cancer-research"],"jetpack_featured_media_url":"https:\/\/coinscreed.com\/staging\/wp-content\/uploads\/2023\/12\/image-5.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/posts\/66181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/comments?post=66181"}],"version-history":[{"count":0,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/posts\/66181\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/media\/66184"}],"wp:attachment":[{"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/media?parent=66181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/categories?post=66181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/coinscreed.com\/staging\/wp-json\/wp\/v2\/tags?post=66181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}